A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Clinical trial NCT02566759 · TERMINATED

Trial details

NCT number: NCT02566759
Sponsor: Neurocrine Biosciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia, Cerebellar Ataxia

Start date: 2015-09-23
Primary completion: 2016-06-09
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.